Featured
Who will survive the next pharma downsize?
A brutal downsizing is coming to pharma with a broad range of roles simply ceasing to exist. Australian experts have revealed the skills and capabilities needed to survive
Latest
AI tool builds synthetic patients and HCPs for pharma
Companies will be able to test messaging and materials in days, rather than months, with responses based on real clinician-patient conversations
Regulatory & Reimbursement
Pfizer touts Australian results
Results of a year-long study conducted in Australia and sponsored by Pfizer has been published JAMA Pediatrics this month reinforcing the effectiveness of its maternal immunisation
Regulatory & Reimbursement
PBAC July meeting winners and losers
Almost three-quarters of the new PBS listing submissions considered by PBAC in July won green light, however many highly anticipated drugs were delivered a blow
Jobs
Featured
PBAC says no to higher price for blockbuster
Company 'disappointed' after the PBAC knocked back a revised submission for the only TGA-approved biologic for uncontrolled severe atopic dermatitis in children under 12 over due to price
Leadership & People
Top GSK prize marks revolution in respiratory care
Researcher recognised for her work in determining why some people suffer life-threatening illnesses from respiratory viruses, potentially transforming the way clinicians predict and manage severe respiratory illness.
Regulatory & Reimbursement
New antibiotic arrives in Australia
Last week the TGA approved a new antibiotic along with a new strength of a lung cancer drug plus generics, and OTCs
Latest
Who's got a new job at an old company?
Job movements continue across industry and it's not always for somewhere new - with two industry executives returning to companies where they've worked before
Industry & Companies
'Rare' uptick in pharma's corporate reputation
Rare disease patient groups have picked their favourite pharma with industry's overall reputation rising to levels not seen for five years - but companies still have plenty to improve on
Regulation & Legal
TGA dishes five-figure prescription drug fine
The Head of the TGA has threatened continued "strong compliance and enforcement action" after the Regulator issued its second significant fine in just over a month
Industry & Companies
Whose share price almost tripled overnight?
New trial results could redefine how cancer patients are treated with two companies experiencing a massive boost in share price and market cap, with one pharma seeing its stock almost triple in value
Featured
Pharma PR campaigns shortlisted for awards
The Golden Target Awards shortlist is out with a strong showing of pharma PR campaigns competing to take home a trophy across a number of categories
Industry & Companies
Aussie company on track to bank its first billion
Australia's largest radiopharma is determined that it's just getting started, increasing R&D spend twice as fast as revenue
Regulation & Legal
Black market booms for future blockbuster
This drug is still months off being filed for approval but there's already a booming black market with the Big Pharma that developed it taking a tough legal stand
Leadership & People
Company bumps up Aussie Leadership Team
The appointment of two experienced industry executives to major roles underlines this pharma's "commitment to investing in world-class talent"
- Other News How many of the best US drugs have reached Australia?
- Industry & Companies Pharma a bright spot in CSL's "reset" year
- Regulatory & Reimbursement Blockbuster earnings nosedive by 80%
- Other News The hidden $1.2B cost of two diseases
- Industry & Companies NEXT Summit in full swing in Sydney
- Regulatory & Reimbursement Swedish pharma launches first drug
- Regulatory & Reimbursement 17 drugs vie for September PBS listing
- Industry & Companies Aussie GMs unpack pricing pain points
